CD161+ MAIT Cells Are Severely Reduced in Peripheral Blood and Lymph Nodes of HIV-Infected Individuals Independently of Disease Progression

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Eberhard, Johanna Maria ^a,b   Hartjen, Philip ^a,b   Kummer, Silke ^a,b   Schmidt, Reinhold E ^c,f   Bockhorn, Maximilian ^a   Lehmann, Clara ^d   Balagopal, Ashwin ^e   Hauber, Joachim ^b,f   Van Lunzen, Jan ^a,b,f   Wiesch, Julian Schulze Zur ^a,b,f  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f German Centre for Infection Research (DZIF) Partner Site Hannover Braunschweig   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD14 ANTIGEN; CD161 ANTIGEN; CD163 ANTIGEN; CHEMOKINE RECEPTOR CCR6; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR; INTERLEUKIN 7; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY B;

ADULT; ARTICLE; BLOOD ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MUCOSAL ASSOCIATED INVARIANT T LYMPHOCYTE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; AGED; BLOOD; CYTOLOGY; DISEASE COURSE; DRUG EFFECTS; HIV INFECTIONS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MUCOSAL IMMUNITY; PATHOLOGY; PHYSIOLOGY;

ADULT; AGED; ANTI-HIV AGENTS; ANTIGENS, CD; ANTIGENS, CD14; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; DISEASE PROGRESSION; ESCHERICHIA COLI; FEMALE; HIV INFECTIONS; HUMANS; IMMUNITY, MUCOSAL; INTERLEUKIN-12; INTERLEUKIN-18; INTERLEUKIN-7; LEUKOCYTES, MONONUCLEAR; LYMPH NODES; MALE; MIDDLE AGED; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, CELL SURFACE; RECEPTORS, INTERLEUKIN-18; T-LYMPHOCYTE SUBSETS;

EID: 84934299884     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111323     Document Type: Article

References (49)

1. Le Bourhis L, Mburu YK, Lantz O (2013) MAIT cells, surveyors of a new class of antigen: development and functions. Curr Opin Immunol 25: 174-180.
2. Le Bourhis L, Dusseaux M, Bohineust A, Bessoles S, Martin E, et al. (2013) MAIT cells detect and efficiently lyse bacterially-infected epithelial cells. PLoS pathogens 9: e1003681.
3. Le Bourhis L, Martin E, Peguillet I, Guihot A, Froux N, et al. (2010) Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol 11: 701-708.
4. Patel O, Kjer-Nielsen L, Le Nours J, Eckle SB, Birkinshaw R, et al. (2013) Recognition of vitamin B metabolites by mucosal-associated invariant T cells. Nature communications 4.
5. Cosgrove C, Ussher JE, Rauch A, Gartner K, Kurioka A, et al. (2013) Early and nonreversible decrease of CD161++/MAIT cells in HIV infection. Blood 121: 951-961.
6. Leeansyah E, Ganesh A, Quigley MF, Sonnerborg A, Andersson J, et al. (2013) Activation, exhaustion, and persistent decline of the antimicrobial MR1- restricted MAIT-cell population in chronic HIV-1 infection. Blood 121: 1124- 1135.
7. Sandberg JK, Dias J, Shacklett BL, Leeansyah E (2013) Will loss of your MAITs weaken your HAART [corrected]? AIDS 27: 2501-2504.
8. Walker BD (2007) Elite control of HIV Infection: implications for vaccines and treatment. Top HIV Med 15: 134-136.
9. Bello G, Velasco-de-Castro CA, Bongertz V, Rodrigues CA, Giacoia-Gripp CB, et al. (2009) Immune activation and antibody responses in non-progressing elite controller individuals infected with HIV-1. J Med Virol 81: 1681-1690.
10. Walker LJ, Kang Y-H, Smith MO, Tharmalingham H, Ramamurthy N, et al. (2012) Human MAIT and CD8aa cells develop from a pool of type-17 precommitted CD8+ T cells. Blood 119: 422-433.
11. Dusseaux M, Martin E, Serriari N, Peguillet I, Premel V, et al. (2011) Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood 117: 1250-1259.
12. Billerbeck E, Kang YH, Walker L, Lockstone H, Grafmueller S, et al. (2010) Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties. Proc Natl Acad Sci U S A 107:.
13. Wong EB, Akilimali NA, Govender P, Sullivan ZA, Cosgrove C, et al. (2013) Low levels of peripheral CD161++CD8+ mucosal associated invariant T (MAIT) cells are found in HIV and HIV/TB co-infection. PLoS One 8: e83474.
14. Chang PP, Barral P, Fitch J, Pratama A, Ma CS, et al. (2012) Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses. Nat Immunol 13: 35-43.
15. King IL, Fortier A, Tighe M, Dibble J, Watts GF, et al. (2012) Invariant natural killer T cells direct B cell responses to cognate lipid antigen in an IL-21- dependent manner. Nat Immunol 13: 44-50.
16. Martin E, Treiner E, Duban L, Guerri L, Laude H, et al. (2009) Stepwise development of MAIT cells in mouse and human. PLoS Biol 7: e54.
17. Le Bourhis L, Guerri L, Dusseaux M, Martin E, Soudais C, et al. (2011) Mucosal-associated invariant T cells: unconventional development and function. Trends Immunol 32: 212-218.
18. Burdo TH, Lo J, Abbara S, Wei J, DeLelys ME, et al. (2011) Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J Infect Dis 204: 1227-1236.
19. Burdo TH, Lentz MR, Autissier P, Krishnan A, Halpern E, et al. (2011) Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy. J Infect Dis 204: 154-163.
20. Sandler NG, Wand H, Roque A, Law M, Nason MC, et al. (2011) Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis 203: 780-790.
21. Ahmad R, Sindhu ST, Toma E, Morisset R, Ahmad A (2002) Elevated levels of circulating interleukin-18 in human immunodeficiency virus-infected individuals: role of peripheral blood mononuclear cells and implications for AIDS pathogenesis. J Virol 76: 12448-12456.
22. Napolitano LA, Grant RM, Deeks SG, Schmidt D, De Rosa SC, et al. (2001) Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med 7: 73-79.
23. Tang XZ, Jo J, Tan AT, Sandalova E, Chia A, et al. (2013) IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells. J Immunol 190: 3142-3152.
24. Ussher JE, Bilton M, Attwod E, Shadwell J, Richardson R, et al. (2014) CD161++ CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+ IL-18 in a TCR-independent manner. European journal of immunology 44: 195-203.
25. Deeks SG, Walker BD (2007) Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 27: 406-416.
26. Pereyra F, Addo MM, Kaufmann DE, Liu Y, Miura T, et al. (2008) Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J Infect Dis 197: 563-571.
27. Northfield JW, Kasprowicz V, Lucas M, Kersting N, Bengsch B, et al. (2008) CD161 expression on hepatitis C virus-specific CD8+ T cells suggests a distinct pathway of T cell differentiation. Hepatology 47: 396-406.
28. Meierovics A, Yankelevich WJ, Cowley SC (2013) MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection. Proc Natl Acad Sci U S A 110: E3119-E3128.
29. Grimaldi D, Le Bourhis L, Sauneuf B, Dechartres A, Rousseau C, et al. (2014) Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intensive Care Med 40: 192-201.
30. Birkinshaw RW, Kjer-Nielsen L, Eckle SB, McCluskey J, Rossjohn J (2014) MAITs, MR1 and vitamin B metabolites. Curr Opin Immunol 26: 7-13.
31. Reantragoon R, Corbett AJ, Sakala IG, Gherardin NA, Furness JB, et al. (2013) Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosalassociated invariant T cells. J Exp Med 210: 2305-2320.
32. Gérart S, Sibéril S, Martin E, Lenoir C, Aguilar C, et al. (2013) Human iNKT and MAIT cells exhibit a PLZF-dependent proapoptotic propensity that is counterbalanced by XIAP. Blood 121: 614-623.
33. Lee OJ, Cho YN, Kee SJ, Kim MJ, Jin HM, et al. (2014) Circulating mucosalassociated invariant T cell levels and their cytokine levels in healthy adults. Exp Gerontol 49: 47-54.
34. Krishnan S, Wilson EM, Sheikh V, Rupert A, Mendoza D, et al. (2014) Evidence for Innate Immune System Activation in HIV Type 1-Infected Elite Controllers. J Infect Dis 209: 931-939.
35. Chun T-W, Shawn Justement J, Murray D, Kim CJ, Blazkova J, et al. (2013) Effect of Antiretroviral Therapy on HIV Reservoirs in Elite Controllers. Journal of Infectious Diseases 208: 1443-1447.
36. Pereyra F, Lo J, Triant VA, Wei J, Buzon MJ, et al. (2012) Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers. AIDS 26: 2409-2412.
37. Turtle CJ, Delrow J, Joslyn RC, Swanson HM, Basom R, et al. (2011) Innate signals overcome acquired TCR signaling pathway regulation and govern the fate of human CD161hi CD8a+ semi-invariant T cells. Blood 118: 2752-2762.
38. Mavigner M, Cazabat M, Dubois M, L'Faqihi FE, Requena M, et al. (2012) Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals. J Clin Invest 122: 62-69.
39. Chen J, Han X, An M, Liu J, Xu J, et al. (2013) Immunological and virological benefits resulted from short-course treatment during primary HIV infection: A meta-analysis. PLoS One 8: e82461.
40. Investigators ST, Fidler S, Porter K, Ewings F, Frater J, et al. (2013) Shortcourse antiretroviral therapy in primary HIV infection. N Engl J Med 368: 207-217.
41. Constantinides MG, Bendelac A (2013) Transcriptional regulation of the NKT cell lineage. Curr Opin Immunol 25: 161-167.
42. Gordon SM, Carty SA, Kim JS, Zou T, Smith-Garvin J, et al. (2011) Requirements for eomesodermin and promyelocytic leukemia zinc finger in the development of innate-like CD8+ T cells. J Immunol 186: 4573-4578.
43. Alonzo ES, Sant'Angelo DB (2011) Development of PLZF-expressing innate T cells. Curr Opin Immunol 23: 220-227.
44. Wakao H, Fujita H (2013) Toward the realization of cell therapy: The advent of MAIT cells from iPSCs. Cell Cycle 12: 2341-2342.
45. Wakao H, Yoshikiyo K, Koshimizu U, Furukawa T, Enomoto K, et al. (2013) Expansion of functional human mucosal-associated invariant T cells via reprogramming to pluripotency and redifferentiation. Cell Stem Cell 12: 546- 558.
46. Wilson NL, Moneyham LD, Alexandrov AW (2013) A systematic review of probiotics as a potential intervention to restore gut health in HIV infection. J Assoc Nurses AIDS Care 24: 98-111.
47. Wong EB, Akilimali NA, Govender P, Sullivan ZA, Cosgrove C, et al. (2013) Low Levels of Peripheral CD161++ CD8+ Mucosal Associated Invariant T (MAIT) Cells Are Found in HIV and HIV/TB Co-Infection. PloS one 8: e83474.
48. Sutton CE, Mielke LA, Mills KHG (2012) IL-17-producing cd T cells and innate lymphoid cells. European Journal of Immunology 42: 2221-2231.
49. Hartjen P, Meyer-Olson D, Lehmann C, Stellbrink HJ, van Lunzen J, et al. (2013) Vgamma2Vdelta2 T cells are skewed toward a terminal differentiation phenotype in untreated HIV infection. J Infect Dis 208: 180-182.